OpenVSafe by OpenVAERS
Search V-safe

2PQ-11456-26310

3 vaccinations 4 coded responses 10 check-ins 4 free-text entries 0 call cases
Sex
—
Age at first dose
31-35
ZIP prefix
080 / NJ
Registered
2021-10-21
Relationship
Self
Race
White
Ethnicity
Hispanic or Latino

Timeline

  1. 2021-03-29
    Dose 1 — Pfizer-BioNTech
  2. 2021-04-19
    Dose 2 — Pfizer-BioNTech
  3. 2021-10-19
    Dose 3 — Pfizer-BioNTech
  4. 2021-10-21
    Registered in v-safe
  5. 2021-10-25
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · Site: Pain, Redness · Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities
    Adult check-in
  6. 2021-10-26
    Health check-in — day 7, dose 3
    Feeling: Good · None
    Adult check-in
  7. 2021-11-02
    Health check-in — day 14, dose 3
    Feeling: Good
    Adult check-in
  8. 2021-11-09
    Health check-in — day 21, dose 3
    Feeling: Good
    Adult check-in
  9. 2021-11-16
    Health check-in — day 28, dose 3
    Feeling: Good
    Adult check-in
  10. 2021-11-23
    Health check-in — day 35, dose 3
    Feeling: Good
    Adult check-in
  11. 2021-11-30
    Survey response — day 42, dose 3
    MedDRA: Colitis, Condition aggravated, Herpes simplex, Pre-existing disease — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities
    Free text: My G.I disease has flared up (HSV-1 Colitis/Postherpetic Neuralgia). Getting the COVID-19 Booster (Pfizer) exacerbated this situation more. All my Doctors have been told.
    MedDRA releases: 2024-11 · check-in free text available
  12. 2022-01-18
    Survey response — 3 months, dose 3
    MedDRA: Enterocolitis viral, Large intestine infection — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities
    Free text: Developed another infection in my colon as consequence of the viral Colitis I have. It has been treated with a protocol of Acyclovir.
    MedDRA releases: 2024-11 · check-in free text available
  13. 2022-04-19
    Survey response — 6 months, dose 3
    MedDRA: Condition aggravated, Office visit, Pre-existing disease — Feeling: Good · Be unable to do your normal daily activities
    Free text: I have been having a new flare up of my G.I condition. Doctors are monitoring though this has postponed my Second COVID-19 Booster.
    MedDRA releases: 2024-11 · check-in free text available
  14. 2022-10-19
    Survey response — 12 months, dose 3
    MedDRA: Fatigue, Influenza, Oropharyngeal pain, Respiratory tract congestion, Sinus headache, Sneezing — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities
    Free text: I became infected with the Flu Virus and experienced sore-throat, fatigue, congestion, sinus headache and sneezing. All symptoms resolved themselves in 4-days except for the congestion which, slowly, has been getting less and less problematic.
    MedDRA releases: 2024-11 · check-in free text available

Vaccinations

DoseDateManufacturerCo-administered
12021-03-29Pfizer-BioNTech No
22021-04-19Pfizer-BioNTech No
32021-10-19Pfizer-BioNTech No

Free text

Release 10 — day 42, dose 3

2021-11-30

Symptoms: My G.I disease has flared up (HSV-1 Colitis/Postherpetic Neuralgia). Getting the COVID-19 Booster (Pfizer) exacerbated this situation more. All my Doctors have been told.

Release 10 — 3 months, dose 3

2022-01-18

Symptoms: Developed another infection in my colon as consequence of the viral Colitis I have. It has been treated with a protocol of Acyclovir.

Release 11 — 6 months, dose 3

2022-04-19

Symptoms: I have been having a new flare up of my G.I condition. Doctors are monitoring though this has postponed my Second COVID-19 Booster.

Release 12 — 12 months, dose 3

2022-10-19

Symptoms: I became infected with the Flu Virus and experienced sore-throat, fatigue, congestion, sinus headache and sneezing. All symptoms resolved themselves in 4-days except for the congestion which, slowly, has been getting less and less problematic.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDColitis · · ✓
SDCondition aggravated · · ✓
SDEnterocolitis viral · · ✓
SDFatigue · · ✓
SDHerpes simplex · · ✓
SDInfluenza · · ✓
SDLarge intestine infection · · ✓
SDOffice visit · · ✓
SDOropharyngeal pain · · ✓
SDPre-existing disease · · ✓
SDRespiratory tract congestion · · ✓
SDSinus headache · · ✓
SDSneezing · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release